T. Rowe Price Associates’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-6,074,699
Closed -$577M – 2622
2018
Q3
$577M Buy
6,074,699
+3,370,668
+125% +$287M 0.08% 238
2018
Q2
$209M Buy
2,704,031
+408,155
+18% +$30.6M 0.03% 471
2018
Q1
$159M Buy
2,295,876
+97,625
+4% +$7.45M 0.03% 516
2017
Q4
$164M Buy
2,198,251
+1,137,814
+107% +$72.8M 0.03% 501
2017
Q3
$67.1M Sell
1,060,437
-91,877
-8% -$5.71M 0.01% 744
2017
Q2
$73.6M Sell
1,152,314
-124,701
-10% -$7.83M 0.01% 696
2017
Q1
$84.2M Sell
1,277,015
-64,814
-5% -$4.46M 0.02% 642
2016
Q4
$92.3M Sell
1,341,829
-5,901
-0.4% -$423K 0.02% 622
2016
Q3
$95.1M Buy
1,347,730
+16,620
+1% +$1.24M 0.02% 588
2016
Q2
$101M Sell
1,331,110
-72,965
-5% -$5.36M 0.02% 561
2016
Q1
$96.4M Buy
1,404,075
+1,381
+0.1% +$99.3K 0.02% 563
2015
Q4
$123M Sell
1,402,694
-22,902
-2% -$1.96M 0.03% 509
2015
Q3
$115M Sell
1,425,596
-72,821
-5% -$6.34M 0.03% 530
2015
Q2
$133M Sell
1,498,417
-25,340
-2% -$2.21M 0.03% 528
2015
Q1
$132M Buy
1,523,757
+17,786
+1% +$1.49M 0.03% 535
2014
Q4
$128M Sell
1,505,971
-48,390
-3% -$3.78M 0.03% 547
2014
Q3
$110M Sell
1,554,361
-200,801
-11% -$14.3M 0.02% 582
2014
Q2
$122M Sell
1,755,162
-2,576,713
-59% -$181M 0.03% 573
2014
Q1
$325M Sell
4,331,875
-2,450,497
-36% -$183M 0.07% 315
2013
Q4
$476M Sell
6,782,372
-2,920,113
-30% -$191M 0.11% 222
2013
Q3
$599M Sell
9,702,485
-100,218
-1% -$6.48M 0.15% 177
2013
Q2
$605M Buy
+9,802,703
New +$590M 0.16% 164

Other funds holding ESRX

T. Rowe Price Associates's ESRX Position: Q4 2018 in Review

T. Rowe Price Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 6,074,699 shares — an estimated $577M sold.

T. Rowe Price Associates first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $605M in Q2 2013. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • T. Rowe Price Associates reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 6,074,699 Express Scripts Holding Company shares in Q4 2018, an estimated $577M.
  • T. Rowe Price Associates first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
  • T. Rowe Price Associates's Express Scripts Holding Company position peaked at $605M in Q2 2013.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.